This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PIK3C3 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PIK3C3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~101.5 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A02356 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | mouse small intestine tissue lysate (catalog A02356) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02356 · 1 μg/ml (catalog A02356) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PIK3C3 is predicted at 101.5 kDa; phosphorylation could affect mobility, but no empirical band or demonstrated migration shift is supplied.
| Band near 101.5 kDa | Consistent with the predicted PIK3C3 size; confirm identity with controls |
| Close doublet near 101.5 kDa | Could reflect different phosphorylation states; separation is not established |
| Band slightly displaced from 101.5 kDa | Phosphorylation may affect mobility, but the cause requires testing |
| Single band without a visible shift | Annotated phosphorylation sites need not produce resolvable bands |
| UniProt predicted mass | Places the reference band near 101.5 kDa |
| AMPK phosphorylation at Thr163 | May affect mobility; no shift is demonstrated |
| AMPK phosphorylation at Ser165 | May affect mobility; no shift is demonstrated |
| Phosphorylation at Ser244 | May affect mobility; no shift is demonstrated |
| Phosphorylation at Ser261 and Ser282 | May affect mobility; no shift is demonstrated |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PIK3C3 occurs at endosomes and autophagosomes; recovery from the preparation may be poor | Check extraction and loading with a positive control |
| Band higher than expected | Phosphorylation is possible, but its effect on migration is unproven | Compare phosphatase-treated material and confirm band identity |
| Band lower than expected | A smaller PIK3C3 product is not established by the supplied features | Check antibody specificity and sample integrity |
| Multiple bands | Different phosphorylation states are possible, but distinct bands are unproven | Compare phosphatase-treated samples and use an independent PIK3C3 antibody |
| Weak or no signal | Recovery of endosomal or autophagosomal PIK3C3 may be limited | Check extraction, loading, and a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Colon | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Low | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Low | Protein (IHC) | HPA → |
| Hippocampus | neuronal cells | Low | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PIK3C3, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-PIK3C3 antibodies report human, mouse, and rat reactivity and have Western blot images. Captions show mouse small intestine lysate for A02356, human cell lysates for A02356-3, and 293T lysate for M02356. No rat blot is supplied.
Which to pick: For mouse small intestine, consider A02356; for human cell lysates, A02356-3 has the most detailed blot conditions and a reported 102 kDa band. M02356 shows a 293T lysate blot. All three list rat reactivity, but none shows a rat sample.